DEA
Surprise! DEA Boss Opposes Marijuana Legalization
Obama's nomination of Michele Leonhart to head the DEA is generating a lot of discussion about how horrible she is. In particular, this exchange from yesterday's Senate hearing is raising disturbing questions about what she'll do with the vast, unchecked drug war powers the President seeks to bestow upon her:
Senate Holds Hearings on Controversial DEA Nominee [FEATURE]
Sen. Orrin Hatch Asks DEA to Ban Spice, K2
Cops Ask Senate to Reject Obama's DEA Nomination Tomorrow (Press Release)
FOR IMMEDIATE RELEASE: November 16, 2010
CONTACT: Tom Angell - (202) 557-4979 or [email protected]
Pro-Legalization Police Group Asks Senate to Vote Against Obama's DEA Nominee
Judiciary Committee to Hold Confirmation Hearing on Wednesday
WASHINGTON, DC -- A group of police officers, judges and prosecutors who support legalizing and regulating marijuana and other drugs has sent a letter to the U.S. Senate Judiciary Committee opposing President Obama's nominee to head the Drug Enforcement Administration (DEA). The nominee, Michele Leonhart, has overseen numerous DEA raids of medical marijuana clinics operating in accordance with state laws during her tenure as acting DEA administrator. This is in direction violation of President Obama's campaign pledges and a Justice Department directive urging the DEA not to waste scarce law enforcement resources undermining the will of voters who have made medical marijuana legal in their states.
"As a police officer, I made arrests of drug users because I was held accountable for enforcing the law whether I agreed with it or not," wrote Neill Franklin, a former Baltimore narcotics cop, in his testimony on behalf of Law Enforcement Against Prohibition (LEAP), which he leads as executive director. "Ms. Leonhart should be held similarly accountable for her actions which were inconsistent with guidance from the Department of Justice, as well as President Obama’s clear intentions based on his popular campaign pledges."
The criminal justice professionals of LEAP are also concerned with Leonhart's apparent disregard for the value of human life, having once called the gruesome violence in Mexico's illegal drug market a sign of "success" for U.S. drug policy.
"The tens of thousands of civilian deaths, which have continued to skyrocket since Ms. Leonhart’s statement, should not be measured as a sign of success," Franklin wrote. "Former Mexican president Vicente Fox and at least three additional former Latin American presidents have pointed out the failure of the US-led war on drugs and called for drastic change. The situation is Mexico is grave and escalating rapidly, putting US citizens in danger. Before the spillover violence gets any worse, the DEA needs a director who can engage world leaders in this debate and come to a solution."
Leonhart has served as acting administrator of the DEA for two years. The hearing to confirm her as administrator takes place before the Senate Judiciary Committee on Wednesday at 2:30 PM in 226 Dirksen Senate Office Building.
# # #
Senator Patrick Leahy, Chairman
Senate Committee on the Judiciary
Tuesday, November 16, 2010
Statement of Major Neill Franklin on behalf of LAW ENFORCEMENT AGAINST PROHIBITION (LEAP) in opposition to the nomination of Ms. Michele Leonhart
Mr. Chairman and distinguished Members of the Committee, thank you for the opportunity to present the views of Law Enforcement Against Prohibition (LEAP) in opposition to the nomination of Michele Leonhart for the position of Director of the U.S. Drug Enforcement Administration (DEA).
After a 33-year career as a police officer, I became the executive director of LEAP, an association of current and former law enforcement officers, prosecutors, judges, and criminal justice professionals at every level of government who are speaking out about the failure of our drug policy.
Our members are deeply concerned about drug abuse and illicit drug market violence, and we have spent our careers fighting the drug war. Several of our members, including Russ Jones of Texas, Matthew Fogg of Washington, D.C., and Richard Amos of Florida, served as DEA agents or on DEA task forces. And as a police officer with the Maryland State Police and the Baltimore Police Department, I too made my share of drug arrests in addition to commanding multi-jurisdictional drug task forces.
We oppose Ms. Leonhart’s nomination because her statements and actions demonstrate questionable judgment. Ms. Leonhart held a press conference regarding Mexican drug prohibition violence last year. Since 2006, more than 28,000 people have died in Mexico as a result of the illegal drug market violence. At the press conference, Ms. Leonhart indicated that such violence was a good sign. “Our view is that the violence we have been seeing is a signpost of the success our very courageous Mexican counterparts are having,” she said. “The cartels are acting out like caged animals, because they are caged animals.”
The tens of thousands of civilian deaths, which have continued to skyrocket since Ms. Leonhart’s statement, should not be measured as a sign of success. Former Mexican president Vicente Fox and at least three additional former Latin American presidents have pointed out the failure of the US-led war on drugs and called for drastic change. The situation is Mexico is grave and escalating rapidly, putting US citizens in danger. Before the spillover violence gets any worse, the DEA needs a director who can engage world leaders in this debate and come to a solution.
Ms. Leonhart’s judgment in allocating resources is questionable. Since her appointment by President Bush, she has overseen more than 200 federal raids in California and other medical marijuana states. When Ms. Leonhart became interim director, these raids continued even after the issuance of the October 19, 2009 Department of Justice memo which recommended federal officials shift resources away from targeting those individuals and organizations operating in compliance with state laws related to medical marijuana.
As a police officer, I made arrests of drug users because I was held accountable for enforcing the law whether I agreed with it or not. Ms. Leonhart should be held similarly accountable for her actions which were inconsistent with guidance from the Department of Justice, as well as President Obama’s clear intentions based on his popular campaign pledges. Under her supervision, a DEA agent raiding a marijuana grower who was operating with the support of the sheriff in Mendocino County, CA, said, “I don’t care what the sheriff says.” This attitude is counterproductive. Given the grave problems associated with illegal drug market violence, we feel that conducting raids on individuals and caretakers acting in compliance with state and local law may not be the best use of the DEA’s limited resources.
The DEA needs a director whose decisions are guided by the best interests of our citizens. Despite calls by the American Medical Association, Ms. Leonhart has failed to respond to a petition calling for hearings to review the scheduling of marijuana. Despite the DEA’s own administrative law judge’s ruling that the University of Massachusetts should be able to cultivate marijuana for FDA-approved research, Ms. Leonhart has blocked such research. We encourage the nomination of a director who supports engaging in dialogue and the use of research to shape the best possible policies.
Ultimately, we feel Ms. Leonhart is not ready for the job of DEA director and qualified candidates are available. In your confirmation hearings, the members of the Judiciary Committee should ask the difficult questions which will determine how she would intend to handle the changing nature of US drug laws. Voters across the country have created a gap between federal policy and state law that is steadily widening. In fifteen states, plus Washington D.C., the medical use of marijuana has been recognized. Several other states may choose to legalize marijuana in the next few years. The director of the DEA must be able to appropriately bridge this divide without wasting resources or causing unnecessary harm.
In the meantime, the criminal justice professionals of Law Enforcement Against Prohibition urge a no vote on Ms. Leonhart’s confirmation as DEA director.
Medical Marijuana Advocates Bring Attention to DEA Confirmation Hearings: Acting DEA Head Michele Leonhart, a Bush-holdover, Led Aggressive Campaign Against Medical Marijuana (Press Release)

FOR IMMEDIATE RELEASE | CONTACT: Americans for Safe Access |
Medical Marijuana Advocates Bring Attention to DEA Confirmation Hearings
Acting DEA head Michele Leonhart, a Bush-holdover, led aggressive campaign against medical marijuana
WASHINGTON - November 15 - After more than two years as acting head of the Drug Enforcement Administration (DEA), Michele Leonhart, who served as Deputy DEA Administrator during George W. Bush's presidency, is scheduled to be confirmed by the Senate Judiciary Committee this Wednesday, November 17th at 2:30pm EST. No friend to medical marijuana patients, Leonhart along with her former boss, DEA Administrator Karen Tandy, were responsible for more than two hundred paramilitary-style raids on patients and their providers. As Acting DEA Administrator, Leonhart has continued to raid dispensaries, growers and medical marijuana testing labs despite a change in federal policy under President Obama.
Although Leonhart is expected to be easily confirmed, advocates want to hold her feet to the fire, and are encouraging Senate Judiciary Committee members to ask tough questions about adherence to President Obama's Justice Department policy and her plans for addressing the growing divide between federal and state medical marijuana laws. "Leonhart's track record of causing untold harm to patients and their providers over the years is cause for a serious lack of trust in the medical marijuana community," said Caren Woodson, Director of Government Affairs with Americans for Safe Access, the country's leading medical marijuana advocacy group, which has submitted questions to be asked of Leonhart during the confirmation hearing. "We need to know that Leonhart has a plan for medical marijuana and the protection of patients and that she will be held accountable for her actions."
What: Michele Leonhart's confirmation hearing to be the next DEA Administrator
When: Wednesday, November 17th at 2:30pm
Where: Senate Judiciary Committee, Dirksen Senate Office Building, Room 226, Washington, DC
In October 2009, the Obama Administration issued a memorandum to U.S. Attorneys discouraging the use of federal resources to prosecute individuals who are in "clear and unambiguous compliance" with their state medical marijuana law. Since then, ASA has tracked more than 30 federal enforcement raids in California, Colorado, Hawaii, and Nevada, all medical marijuana states. By contrast, local and state governments are recognizing the need for, and authorizing methods of, distribution of medical marijuana. In a grassroots push over the next two days, medical marijuana advocates across the country are calling on Senate Judiciary Committee members to ask hard questions of Leonhart. "Leonhart must look at this as a public health issue and do more to reconcile the conflict between local, state and federal laws," continued Woodson.
In addition to enforcement, as head of the DEA, Leonhart will have authority over an unanswered marijuana Rescheduling petition that has been pending since 2002. Filed by the Coalition for Rescheduling Cannabis (CRC), the petition originally argued before the Bush Administration that marijuana has medical value and should be rescheduled. Now before the Obama Administration, advocates and coalition members are expecting more rigorous scrutiny on an issue that has been progressively moving toward scientific and mainstream acceptance. This past week it was confirmed that Arizona, which narrowly voted for Proposition 203, would become the country's 15th state to pass a medical marijuana law.
Under the authority of the Controlled Substances Act, Leonhart has significant control over medical marijuana research in the U.S., and has used her position as Acting Administrator to obstruct the scientific advancement of this important therapeutic substance. In January 2009, days before President Bush was to vacate his office, Acting Administrator Leonhart thwarted an effort to end federal obstruction of medical marijuana research, ignoring an 87-page recommendation from her own DEA Administrative Law Judge Mary Ellen Bittner, who ruled that such research was "in the public interest." The DEA and the National Institute for Drug Abuse (NIDA) have colluded to obstruct medical efficacy studies by prioritizing research on the supposed harmful effects of marijuana.
Further information:
Leonhart confirmation hearing notice: http://judiciary.senate.gov/hearings/hearing.cfm?id=4850
ASA Questions for Leonhart: http://AmericansForSafeAccess.org/downloads/ASA_Leonhart_Questions.pdf
ASA Memo to Senate Judiciary Committee: http://AmericansForSafeAccess.org/downloads/ASA_Leonhart_Memo.pdf
Dr. Mollie Fry's Medical Marijuana Conviction Upheld
Stop Stifling Proposition 19 Supporters (Action Alert)
|
Oops! Obama Offends DEA With Drug War Comments
Quote of the Day
Last week's Wall Street Journal op-ed from nine former DEA administrators resulted in
Pagination
- First page
- Previous page
- …
- 49
- 50
- 51
- 52
- 53
- …
- Next page
- Last page
